Cargando…
Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients
BACKGROUND: The immune checkpoint of programmed cell death ligand 1 (PD-L1) commonly expressed in solid cancers, and the blockade of this molecule show promising results in advanced cancers, including lung cancer. The relevance of PD-L1 to patient-derived xenograft (PDX) formation and clinicopatholo...
Autores principales: | Ma, Yuanyuan, Zhang, Panpan, An, Guo, Zhang, Xiaolong, Zhang, Liyi, Si, Jiahui, Zhang, Jianzhi, Yang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087670/ https://www.ncbi.nlm.nih.gov/pubmed/27784882 http://dx.doi.org/10.12659/MSM.900661 |
Ejemplares similares
-
Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy
por: Zhang, Panpan, et al.
Publicado: (2016) -
Therapeutic Effect of an Anti-Human Programmed Death-Ligand 1 (PD-L1) Nanobody on Polymicrobial Sepsis in Humanized Mice
por: Zhao, Zhen-zhen, et al.
Publicado: (2021) -
The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas
por: Liu, Shujun, et al.
Publicado: (2020) -
Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer
por: Zhang, Jian, et al.
Publicado: (2019) -
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)
por: Michikawa, Chieko, et al.
Publicado: (2022)